A20 protects mice from D-galactosamine/lipopolysaccharide acute toxic lethal hepatitis

Hepatology

Volumn 35, Issue 3, 2002, Pages 535-543

  Arvelo, Maria B ^a   Cooper, Jeffrey T ^a   Longo, Christopher ^a   Daniel, Soizic ^a   Grey, Shane T ^a   Mahiou, Jerome ^a   Czismadia, Eva ^a   Abu Jawdeh, Graziella ^b   Ferran, Christiane ^a,b  

^a TUFTS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; GALACTOSAMINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; PROTEIN; PROTEIN A20; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ACUTE HEPATITIS; ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; GENE THERAPY; HUMAN; HUMAN CELL; LIVER CELL; LIVER FAILURE; LIVER REGENERATION; MALE; METABOLIC INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL RATE; TOXIC HEPATITIS;

EID: 0036189282     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2002.31309     Document Type: Article

References (42)

1. Apoptosis in liver disease
2. Intrahepatic T cells in hepatitis B: Viral control versus liver cell injury
3. The role of virus-specific CD8+ cells in liver damage and viral control during persistent Hepatitis B infection
4. Acute Liver Failure
5. Acute liver failure: Clinical features, outcome analysis, and applicability of prognostic criteria
6. BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death
7. Differential protective effects of Bcl-xL and Bcl-2 on apoptotic liver injury in transgenis mice
8. Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice
9. Galactosamine-induced sensitization to the lethal effects of endotoxin
10. Animal models of acute hepatic failure
11. The A20 cDNA induced by tumor necrosis factor alpha encodes a novel type of zinc finger protein
12. The A20 zinc finger protein protects cells from TNF cytotoxicity
13. Activation of the B-cell surface receptor CD40 induces A20, a novel zinc finger protein that inhibits apoptosis
14. A20 inhibits cytokine-induced apoptosis and nuclear factor κB-dependent gene activation in islets
15. A20 inhibits NF-κB activation in endothelial cells without sensitizing to TNF-mediated apoptosis
16. A20 blocks endothelial cell activation through a NF-κB-dependent mechanism
17. Overexpression of A20 in endothelial cells of vascularized Grafts creates a protective barrier against TNF and FAS-mediated apoptosis
18. Human T cell leukemia virus type I Tax and phorbol 12-myristate 13-acetate induce expression of the A20 zinc finger protein by distinct mechanisms involving nuclear factor κB
19. Protective genes expressed in endothelial cells: A regulatory response to injury
20. Failure to regulate TNF-induced NF-κB and cell death responses in A20-deficient mice
21. Expression of a truncated form of the human p55 TNF-Receptor in bovine aortic endothelial cells renders them resistant to human TNF
22. Liver Transplantation
23. NF-κB: Ten years later
24. Assessment of recombinant adenoviral vectors for hepatic gene therapy
25. Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver
26. Liver-directed gene therapy: Prospects and problems
27. A bcl-2 transgene expressed in hepatocytes protects mice from fulminant liver destruction but not from rapid death induced by anti-Fas antibody
28. Inhibition of Fas-mediated fulminant hepatitis in CrmA gene-transfecred mice
29. Activation of Fas by FasL induces apoptosis by a mechanism that cannot be blocked by Bcl-2 or Bcl-xL
30. TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB
31. Hepatitis C virus core protein inhibits Fas- and tunor necrosis factor alpha-mediated apoptosis via NF-κB activation
32. Redox gene therapy for ishemia/reperfusion injury of the liver reduces AP1 and NF-κB activation
33. Suppression of TNF-α-induced apoptosis by NF-κB
34. Interleukin 10 reduces lethality and hepatic injury induced by lipolysaccharide in galctosamine-sensitized mice
35. Protective role of interleukin 6 in the lipopolysaccharide-galactosamine septic shock model
36. Initiation of liver growth by tumor necrosis factor: Deficient liver regeneration in mice lacking type I tumor necrosis factor receptor
37. NF-κB prevents apoptosis and liver dysfunction during liver regeneration
38. Essential roles of the Fas ligand in the development of hepatitis
39. Fas engagement accelerates liver regeneration after partial hepatectomy
40. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice
41. Liver regeneration
42. Viral vectors for gene therapy: The art of turning infectious agents into vehicles of therapeutics